Literature DB >> 25014971

A Novel Classification Method for Prediction of Rectal Bleeding in Prostate Cancer Radiotherapy Based on a Semi-Nonnegative ICA of 3D Planned Dose Distributions.

Julie Coloigner, Auréline Fargeas, Amar Kachenoura, Lu Wang, Gaël Dréan, Caroline Lafond, Lotfi Senhadji, Renaud de Crevoisier, Oscar Acosta, Laurent Albera.   

Abstract

The understanding of dose/side-effects relationships in prostate cancer radiotherapy is crucial to define appropriate individual's constraints for the therapy planning. Most of the existing methods to predict side-effects do not fully exploit the rich spatial information conveyed by the three-dimensional planned dose distributions. We propose a new classification method for three-dimensional individuals' doses, based on a new semi-nonnegative ICA algorithm to identify patients at risk of presenting rectal bleeding from a population treated for prostate cancer. The method first determines two bases of vectors from the population data: the two bases span vector subspaces, which characterize patients with and without rectal bleeding, respectively. The classification is then achieved by calculating the distance of a given patient to the two subspaces. The results, obtained on a cohort of 87 patients (at two year follow-up) treated with radiotherapy, showed high performance in terms of sensitivity and specificity.

Entities:  

Mesh:

Year:  2014        PMID: 25014971     DOI: 10.1109/JBHI.2014.2328315

Source DB:  PubMed          Journal:  IEEE J Biomed Health Inform        ISSN: 2168-2194            Impact factor:   5.772


  2 in total

1.  Detecting spatial susceptibility to cardiac toxicity of radiation therapy for lung cancer.

Authors:  Xiaonan Liu; Mirek Fatyga; Steven E Schild; Jing Li
Journal:  IISE Trans Healthc Syst Eng       Date:  2020-07-22

2.  Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy.

Authors:  L E A Shelley; J E Scaife; M Romanchikova; K Harrison; J R Forman; A M Bates; D J Noble; R Jena; M A Parker; M P F Sutcliffe; S J Thomas; N G Burnet
Journal:  Radiother Oncol       Date:  2017-04-28       Impact factor: 6.280

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.